Chan, Kevin E <br/><br/>
Combined angiotensin-converting enzyme inhibition and receptor blockade associate with increased risk of cardiovascular death in hemodialysis patients.  [electronic resource] 

 -  Kidney international  Nov 2011 
 - 978-985 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1523-1755 
<br/><br/><label>Standard No.: </label>10.1038/ki.2011.228  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Angiotensin II Type 1 Receptor Blockers--adverse effects<br/>Angiotensin-Converting Enzyme Inhibitors--adverse effects<br/>Antihypertensive Agents--adverse effects<br/>Cardiovascular Diseases--etiology<br/>Drug Therapy, Combination<br/>Female<br/>Humans<br/>Hypertension--complications<br/>Kaplan-Meier Estimate<br/>Kidney Failure, Chronic--complications<br/>Logistic Models<br/>Male<br/>Middle Aged<br/>Propensity Score<br/>Proportional Hazards Models<br/>Renal Dialysis--mortality<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Survival Rate<br/>Time Factors<br/>Treatment Outcome<br/>United States--epidemiology